AbbVie Announces Major $380 Million Investment to Enhance Pharmaceutical Production in North Chicago AbbVie is set to invest $380 million in North Chicago for the construction of two new manufacturing facilities, focusing on advanced neuroscience and obesity medications.

AbbVie Announces Major $380 Million Investment to Enhance Pharmaceutical Production in North Chicago #United_States #Active_Pharmaceutical_Ingredient #AbbVie #North_Chicago

AbbVie Invests $195 Million to Boost U.S. API Manufacturing Capacity AbbVie is investing $195 million in its North Chicago facility to enhance active pharmaceutical ingredient production, promoting domestic capacity.

AbbVie Invests $195 Million to Boost U.S. API Manufacturing Capacity #United_States #Active_Pharmaceutical_Ingredient #AbbVie #North_Chicago

Global Active Pharmaceutical Ingredient Market Expected To Reach USD 328.95 Billion By 2030 The Active Pharmaceutical Ingredient market is projected to rise significantly, reaching USD 328.95 billion by 2030, driven by numerous healthcare and technological factors.

Global Active Pharmaceutical Ingredient Market Expected To Reach USD 328.95 Billion By 2030 #None #pharmaceuticals #Active_Pharmaceutical_Ingredient #API